Correlation Between Cognition Therapeutics and Bright Minds
Can any of the company-specific risk be diversified away by investing in both Cognition Therapeutics and Bright Minds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cognition Therapeutics and Bright Minds into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cognition Therapeutics and Bright Minds Biosciences, you can compare the effects of market volatilities on Cognition Therapeutics and Bright Minds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cognition Therapeutics with a short position of Bright Minds. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cognition Therapeutics and Bright Minds.
Diversification Opportunities for Cognition Therapeutics and Bright Minds
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cognition and Bright is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Cognition Therapeutics and Bright Minds Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bright Minds Biosciences and Cognition Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cognition Therapeutics are associated (or correlated) with Bright Minds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bright Minds Biosciences has no effect on the direction of Cognition Therapeutics i.e., Cognition Therapeutics and Bright Minds go up and down completely randomly.
Pair Corralation between Cognition Therapeutics and Bright Minds
Given the investment horizon of 90 days Cognition Therapeutics is expected to under-perform the Bright Minds. But the stock apears to be less risky and, when comparing its historical volatility, Cognition Therapeutics is 1.3 times less risky than Bright Minds. The stock trades about -0.11 of its potential returns per unit of risk. The Bright Minds Biosciences is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 4,680 in Bright Minds Biosciences on September 1, 2024 and sell it today you would lose (280.00) from holding Bright Minds Biosciences or give up 5.98% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cognition Therapeutics vs. Bright Minds Biosciences
Performance |
| Timeline |
| Cognition Therapeutics |
| Bright Minds Biosciences |
Cognition Therapeutics and Bright Minds Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cognition Therapeutics and Bright Minds
The main advantage of trading using opposite Cognition Therapeutics and Bright Minds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cognition Therapeutics position performs unexpectedly, Bright Minds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Minds will offset losses from the drop in Bright Minds' long position.| Cognition Therapeutics vs. Reviva Pharmaceuticals Holdings | Cognition Therapeutics vs. Eyenovia | Cognition Therapeutics vs. Transcode Therapeutics | Cognition Therapeutics vs. Kodiak Sciences |
| Bright Minds vs. Revelation Biosciences | Bright Minds vs. Zura Bio Limited | Bright Minds vs. Phio Pharmaceuticals Corp | Bright Minds vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |